Amid profit forecast reductions, Pfizer is implementing a $7.7bn cost-cutting strategy, while investing into its ...

Pfizer on Tuesday forecast 2026 profit below Wall Street estimates as it expects a steep drop in sales of its COVID products ...

Pfizer last month closed its up to $10bn (€8.5bn) acquisition of Metsera after winning shareholder approval, gaining a ...

President Trump announced landmark drug pricing agreements with nine pharmaceutical companies and the launch of TrumpRx.gov, aiming to lower US medicine prices and align them with Europe while warning ...

J&J believes 10 of its new products/pipeline candidates in the Innovative Medicine segment have the potential to deliver peak ...

The president made a wide variety of claims Wednesday night. Some were true, some were misleading, and others were false.

Alphabet, Amazon, Meta and Microsoft—and, more recently, Oracle have poured money into data centres crammed full of pricey AI ...

The talks follow the administration’s push to lower U.S. drug prices using trade and regulatory leverage. ・Pfizer and ...

Trouble for Simon Harris is that GDP figures don’t tend to cheer you up if you are juggling a long commute, childcare costs ...

The U.S. stock market drifted through a mixed day of trading Dec. 16 after reports on the economy did little to clear ...

Morning Brief host Julie Hyman breaks down the biggest market stories developing on December 16, 2025. RSM chief economist ...

She arrived ten minutes early, already tired. A thick packet of paperwork rested in her lap, filled with questions she had answered last year and the year before — her medications, surgeries, daily ...